DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH NEUROMEDIN U2 RECEPTOR (NMU2)

Details for Australian Patent Application No. 2003233326 (hide)

Owner BAYER AKTIENGESELLSCHAFT

Inventors GEERTS, Andreas; GOLZ, Stefan; BRUGGEMEIER, Ulf

Pub. Number AU-A-2003233326

PCT Number PCT/EP03/05043

PCT Pub. Number WO2003/100435

Priority 02011529.1 23.05.02 EP

Filing date 14 May 2003

Wipo publication date 12 December 2003

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 038/11 Medicinal preparations containing peptides

A61P 005/10 Drugs for disorders of the endocrine system

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 02011529.1 23.05.02 EP

5 February 2004 Application Open to Public Inspection

  Published as AU-A-2003233326

10 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003233327-METHOD FOR THE PRODUCTION OF A MONOLITHIC MULTILAYER ACTUATOR, MONOLITHIC MULTILAYER ACTUATOR MADE OF A PIEZOCERAMIC OR ELECTROSTRICTIVE MATERIAL, AND EXTERNAL ELECTRICAL CONTACT FOR A MONOLITHIC MULTILAYER ACTUATOR

2003233325-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH ARGININE VASOPRESSIN RECEPTOR 2 (AVPR2)